摘要:
The present invention relates to a plant extract for treating diabetes and a process for making same. The plant extract of the invention is prepared from an overground part of Hedychium coronarium Koenig, which has the efficacies of lowering blood glucose, increasing insulin levels, reducing insulin resistance and treating and/or preventing diabetes without overly reducing blood glucose in a subject, i.e., not reducing blood glucose in a fasting subject. Also provided herein is a method for treating diabetes in a subject in need thereof comprising administering an effective amount of the plant extract to the subject.
摘要:
The present invention relates to a plant extract for treating diabetes and a process for making same. The plant extract of the invention is prepared from an overground part of Hedychium coronarium Koenig, which has the efficacies of lowering blood glucose, increasing insulin levels, reducing insulin resistance and treating and/or preventing diabetes without overly reducing blood glucose in a subject, i.e., not reducing blood glucose in a fasting subject. Also provided herein is a method for treating diabetes in a subject in need thereof comprising administering an effective amount of the plant extract to the subject.
摘要:
A compound for controlling blood glucose level has a structure shown in Formula I: wherein R5-R8 are as defined herein. A method for controlling blood glucose level includes administering to a subject in need thereof a compound of Formula I. The method further includes administering to the subject a GLP-1 receptor ligand. The compound and the GLP-1 receptor ligand may be administered together. The compound may be Galanal A or Galanal B. The GLP-1 receptor ligand may be GLP-1 or exendin-4.
摘要翻译:用于控制血糖水平的化合物具有式I所示的结构:其中R5-R8如本文所定义。 用于控制血糖水平的方法包括向有需要的受试者施用式I的化合物。该方法还包括向受试者施用GLP-1受体配体。 化合物和GLP-1受体配体可以一起施用。 该化合物可以是Galanal A或Galanal B. GLP-1受体配体可以是GLP-1或毒蜥外泌肽-4。
摘要:
A compound for controlling blood glucose level has a structure shown in Formula I: wherein R5-R8 are as defined herein. A method for controlling blood glucose level includes administering to a subject in need thereof a compound of Formula I. The method further includes administering to the subject a GLP-1 receptor ligand. The compound and the GLP-1 receptor ligand may be administered together. The compound may be Galanal A or Galanal B. The GLP-1 receptor ligand may be GLP-1 or exendin-4.
摘要翻译:用于控制血糖水平的化合物具有式I所示的结构:其中R5-R8如本文所定义。 用于控制血糖水平的方法包括向有需要的受试者施用式I的化合物。该方法还包括向受试者施用GLP-1受体配体。 化合物和GLP-1受体配体可以一起施用。 该化合物可以是Galanal A或Galanal B. GLP-1受体配体可以是GLP-1或毒蜥外泌肽-4。
摘要:
A method implemented by a computer layout software for setting the width of the printed circuit board trace is disclosed. The method selects one from several traces set on the printed circuit board traces, obtains the corresponding trace name of the selected trace, obtains the device pin connected to the selected trace, acquires the pad corresponding to the device pin, reads the width of the pad, and adjusts the width of the pad.
摘要:
A paper reel includes a lining, and an enclosure mounted on a periphery of the lining. Thus, the plastic enclosure encompasses a whole length of the paper lining to reinforce the strength of the paper reel, so that when an element, such as a tape, cloth, weaving strap, metallic foil, car insulating paper or the like, is closely wound around the paper reel, the paper reel will not be deformed or distorted due to compression, thereby enhancing the quality and stability of the paper reel.
摘要:
Disclosed are new fluorogenic substrates for assay of angiotensin converting enzyme, a process for preparing them and methods for using them to assay angiotensin converting enzyme and to screen antihypertensive agents which inhibit angiotensin converting enzyme.
摘要:
Disclosed herein are methods of determining the sequence and/or positions of modified bases in a nucleic acid sample present in a circular molecule with a nucleic acid insert of known sequence comprising obtaining sequence data of at least two insert-sample units. In some embodiments, the methods comprise obtaining sequence data using circular pair-locked molecules. In some embodiments, the methods comprise calculating scores of sequences of the nucleic acid inserts by comparing the sequences to the known sequence of the nucleic acid insert, and accepting or rejecting repeats of the sequence of the nucleic acid sample according to the scores of one or both of the sequences of the inserts immediately upstream or downstream of the repeats of the sequence of the nucleic acid sample.
摘要:
A gate structure includes a gate disposed on a substrate, a first spacer disposed on the substrate and surrounding the gate and a second spacer disposed on the first spacer and surrounding the gate, the second spacer is lower than the first spacer.